Oxford Immunotec Global PLC (OXFD) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
94C INNOVATION DRIVE ABINGDON, OX14 4RZ |
| State of Incorp. | |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2835 - In Vitro and In Vivo Diagnostic Substances (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
| 9/30/2020 Q3 | 6/30/2020 Q2 | 3/31/2020 Q1 | 12/31/2019 Q4 | 9/30/2019 Q3 | 6/30/2019 Q2 | 3/31/2019 Q1 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 165,489 | 166,485 | 181,270 | 184,282 | 187,291 | 189,518 | |||
| Cash and cash equivalents | 165,489 | 166,485 | 181,270 | 184,282 | 187,291 | 189,518 | |||
| Receivables | 4,861 | 17,920 | 18,329 | 24,192 | 22,893 | 14,715 | |||
| Inventory, net of allowances, customer advances and progress billings | 12,824 | 10,854 | 11,096 | 9,800 | 9,957 | 9,944 | |||
| Inventory | 12,824 | 10,854 | 11,096 | 9,800 | 9,957 | 9,944 | |||
| Contract with customer, asset, after allowance for credit loss | 1,600 | 1,600 | 1,600 | ||||||
| Other undisclosed current assets | 2,175 | 3,857 | 3,586 | 3,157 | 3,199 | 4,038 | |||
| Total current assets: | 186,949 | 200,716 | 215,881 | 221,431 | 223,340 | 218,215 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 6,638 | 6,824 | 7,443 | 6,662 | 6,892 | 7,223 | |||
| Property, plant and equipment | 8,561 | 7,314 | 7,095 | 6,378 | 6,658 | 7,066 | |||
| Intangible assets, net (including goodwill) | 2,555 | 2,558 | 2,570 | 2,526 | 2,533 | 2,539 | |||
| Goodwill | 2,483 | 2,483 | 2,483 | 2,483 | 2,483 | 2,483 | |||
| Intangible assets, net (excluding goodwill) | 72 | 75 | 87 | 43 | 50 | 56 | |||
| Restricted cash and investments | 100 | 100 | 100 | 100 | 100 | 100 | |||
| Deferred income tax assets | 1,744 | 1,570 | 2,163 | ||||||
| Other noncurrent assets | 59 | ||||||||
| Other undisclosed noncurrent assets | 1,869 | 2,508 | 6,167 | ||||||
| Total noncurrent assets: | 19,657 | 18,366 | 19,371 | 17,535 | 18,691 | 23,095 | |||
| TOTAL ASSETS: | 206,606 | 219,082 | 235,252 | 238,966 | 242,031 | 241,310 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 9,747 | 12,951 | 12,816 | 11,803 | 11,746 | 12,492 | |||
| Accounts payable | 1,658 | 4,461 | 2,420 | 3,085 | 2,519 | 3,115 | |||
| Accrued liabilities | 8,089 | 8,490 | 10,396 | 8,718 | 9,227 | 9,377 | |||
| Deferred revenue | 34 | 43 | 19 | 174 | 214 | 213 | |||
| Debt | 984 | 533 | 480 | 484 | |||||
| Other undisclosed current liabilities | 1,031 | 1,038 | 4,218 | 4,289 | 4,130 | ||||
| Total current liabilities: | 10,812 | 14,032 | 13,819 | 16,728 | 16,729 | 17,319 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 6,869 | 7,042 | 7,742 | 7,269 | 7,519 | 7,812 | |||
| Long-term debt, excluding current maturities | 32 | 32 | 30 | 30 | 30 | ||||
| Liabilities, other than long-term debt | 32 | ||||||||
| Other liabilities | 32 | ||||||||
| Operating lease, liability | 6,869 | 7,010 | 7,710 | 7,239 | 7,489 | 7,782 | |||
| Other undisclosed noncurrent liabilities | (7,010) | ||||||||
| Total noncurrent liabilities: | 6,901 | 7,042 | 7,742 | 7,269 | 7,519 | 7,812 | |||
| Total liabilities: | 17,713 | 21,074 | 21,561 | 23,997 | 24,248 | 25,131 | |||
| Equity | |||||||||
| Equity, attributable to parent | 188,893 | 198,008 | 213,691 | 214,969 | 217,783 | 216,179 | |||
| Common stock | 272 | 272 | 276 | 278 | 280 | 278 | |||
| Additional paid in capital | 300,231 | 299,574 | 304,909 | 306,601 | 307,882 | 305,515 | |||
| Accumulated other comprehensive loss | (10,275) | (10,188) | (7,461) | (10,425) | (8,711) | (7,356) | |||
| Accumulated deficit | (101,335) | (91,650) | (84,033) | (81,485) | (81,668) | (82,258) | |||
| Total equity: | 188,893 | 198,008 | 213,691 | 214,969 | 217,783 | 216,179 | |||
| TOTAL LIABILITIES AND EQUITY: | 206,606 | 219,082 | 235,252 | 238,966 | 242,031 | 241,310 | |||
Income Statement (P&L) ($ in thousands)Annual | Quarterly
| 9/30/2020 Q3 | 6/30/2020 Q2 | 3/31/2020 Q1 | 12/31/2019 Q4 | 9/30/2019 Q3 | 6/30/2019 Q2 | 3/31/2019 Q1 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 5,835 | 13,911 | 18,114 | 21,219 | 19,588 | 14,789 | ||
| Cost of revenue (Cost of Goods and Services Sold) | (2,170) | (3,604) | (3,929) | (5,731) | (5,400) | (4,228) | ||
| Gross profit: | 3,665 | 10,307 | 14,185 | 15,488 | 14,188 | 10,561 | ||
| Operating expenses | (13,499) | (16,890) | (16,100) | (15,366) | (15,169) | (13,910) | ||
| Operating income (loss): | (9,834) | (6,583) | (1,915) | 122 | (981) | (3,349) | ||
| Nonoperating income (expense) | (124) | 963 | (1,713) | 383 | 333 | (884) | ||
| Gain (loss), foreign currency transaction, before tax | (124) | 963 | (1,716) | 360 | 291 | (884) | ||
| Other undisclosed income from continuing operations before equity method investments, income taxes | 4,247 | |||||||
| Income (loss) from continuing operations before equity method investments, income taxes: | (9,958) | (5,620) | 619 | 505 | (648) | (4,233) | ||
| Other undisclosed income (loss) from continuing operations before income taxes | 118 | 619 | (3,426) | 1,064 | 1,162 | 1,200 | ||
| Income (loss) from continuing operations before income taxes: | (9,840) | (5,001) | (2,807) | 1,569 | 514 | (3,033) | ||
| Income tax expense (benefit) | 136 | (209) | 1,187 | (383) | 76 | 1,537 | ||
| Income (loss) from continuing operations: | (9,704) | (5,210) | (1,620) | 1,186 | 590 | (1,496) | ||
| Income (loss) before gain (loss) on sale of properties: | (9,685) | (5,210) | (1,620) | 717 | 590 | (1,496) | ||
| Income (loss) from discontinued operations | 19 | (469) | ||||||
| Net income (loss): | (9,685) | (5,210) | (1,620) | 717 | 590 | (1,496) | ||
| Other undisclosed net loss attributable to parent | (817) | |||||||
| Net income (loss) available to common stockholders, diluted: | (9,685) | (6,027) | (1,620) | 717 | 590 | (1,496) | ||
Comprehensive Income ($ in thousands)Annual | Quarterly
| 9/30/2020 Q3 | 6/30/2020 Q2 | 3/31/2020 Q1 | 12/31/2019 Q4 | 9/30/2019 Q3 | 6/30/2019 Q2 | 3/31/2019 Q1 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | (9,685) | (5,210) | (1,620) | 717 | 590 | (1,496) | ||
| Other comprehensive income (loss) | (47) | 679 | 335 | (426) | (379) | (319) | ||
| Comprehensive income (loss): | (9,732) | (4,531) | (1,285) | 291 | 211 | (1,815) | ||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | (40) | (4,223) | 2,629 | (1,288) | (976) | 1,486 | ||
| Comprehensive income (loss), net of tax, attributable to parent: | (9,772) | (8,754) | 1,344 | (997) | (765) | (329) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.